a nonsignificant trendp =0.06
One RCT reported a nonsignificant trend for shorter survival when taking oral opioids compared to intrathecal opioids for pain control (6-month survival 37% versus 54%, p =0.06).
One RCT reported a nonsignificant trend for shorter survival when taking oral opioids compared to intrathecal opioids for pain control (6-month survival 37% versus 54%, p =0.06).
Length of opioid treatment may be significant in patients with cancer.